霍奇金淋巴瘤（霍奇金病）

预约门诊

生存率

对于大多数霍奇金淋巴瘤患者，存活概率相当乐观。为了解淋巴瘤的生存率，专家会研究大量淋巴瘤患者，观察他们在确诊后 5 年内的存活人数。

对于 1 期霍奇金淋巴瘤，患者确诊后至少存活 5 年的概率为 92%。随着癌症扩散，存活概率会降低。对于 4 期霍奇金淋巴瘤，患者确诊后至少存活 5 年的概率约为 82%。

需注意生存统计数据需要 5 年时间采集。最新的生存率数据包含 5 年前接受过淋巴瘤治疗的患者。这些患者可能未接触过最新疗法。在过去数十年间，淋巴瘤的死亡率持续下降，生存率稳步提升。

申请预约
分期医生与科室
Sept. 24, 2025

Living with 霍奇金淋巴瘤（霍奇金病）?

Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient community.

Blood Cancers & Disorders Discussions

amyboylan1
Is there anything to help stop or slow progression of MGUS?

166 Replies Sun, Feb 08, 2026

dtrgran59
What are my chances that MGUS turns into multiple myeloma?

42 Replies Thu, Feb 05, 2026

Lori, Volunteer Mentor
My Bone Marrow Transplant (BMT/SCT) story: Will you share yours?

823 Replies Sun, Feb 08, 2026

See more discussions
  1. Hodgkin lymphoma. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1439. Accessed Aug. 19, 2025.
  2. Hodgkin lymphoma treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/lymphoma/patient/adult-hodgkin-treatment-pdq. Accessed Aug. 19, 2025.
  3. Elsevier Point of Care. Clinical Overview: Hodgkin lymphoma. https://www.clinicalkey.com. Accessed Aug. 19, 2025.
  4. Cancer stat facts: Hodgkin lymphoma. National Cancer Institute. https://seer.cancer.gov/statfacts/html/hodg.html. Accessed Aug. 19, 2025.
  5. Hoffman R, et al. Hodgkin lymphoma. In: Hematology: Basic Principles and Practice. 8th ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed Aug. 19, 2025.
  6. Ferri FF. Hodgkin lymphoma. In: Ferri's Clinical Advisor 2026. Elsevier; 2026. https://www.clinicalkey.com. Accessed Aug. 19, 2025.
  7. Ng AK, et al. Classic Hodgkin lymphoma: Presentation, evaluation, and diagnosis in adults. https://www.uptodate.com/contents/search. Accessed Aug. 19, 2025.
  8. LaCasce AS, et al. Pretreatment evaluation, staging, and treatment stratification of classic Hodgkin lymphoma. https://www.uptodate.com/contents/search. Accessed Aug. 19, 2025.
  9. LaCasce AS. Treatment of relapsed or refractory classic Hodgkin lymphoma. https://www.uptodate.com/contents/search. Accessed Aug. 19, 2025.
  10. Chemotherapy to treat cancer. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/chemotherapy#chemotherapy-can-cause-side-effects. Accessed Aug. 19, 2025.
  11. Radiation therapy side effects. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy/side-effects. Accessed Aug. 19, 2025.
  12. Laurent C, et al. Impact of expert pathologic review of lymphoma diagnosis: Study of patients from the French Lymphopath Network. Journal of Clinical Oncology. 2017; doi:10.1200/JCO.2016.71.2083.
  13. Goyal G, et al. Association between facility volume and mortality of patients with classic Hodgkin lymphoma. Cancer. 2019; doi:10.1002/cncr.32584.
  14. Member institutions. Alliance for Clinical Trials in Oncology. https://www.allianceforclinicaltrialsinoncology.org/main/public/standard.xhtml?path=%2FPublic%2FInstitutions. Accessed Aug. 19, 2025.
  15. Membership institution lists. NRG Oncology. https://www.nrgoncology.org/About-Us/Membership/Member-Institution-Lists. Accessed Aug. 19, 2025.
  16. Stem cell transplants in cancer treatments. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant#stem-cell-transplant-side-effects. Accessed Aug. 19, 2025.
  17. Elsevier Point of Care. Clinical Overview: Febrile neutropenia in adults. https://www.clinicalkey.com. Accessed Aug. 19, 2025.
  18. Immunotherapy side effects. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects. Accessed Aug. 19, 2025.
  19. Targeted therapy to treat cancer. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies. Accessed Aug. 19, 2025.

相关

相关医疗程序

Mayo Clinic 新闻

产品与服务

霍奇金淋巴瘤（霍奇金病）